Skip to content
Biodatica
Start free

Janssen Scientific Affairs, LLC

Houston, Texas

OncologyFiled/ApprovedListed · JNJ

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Study registered, no phase assigned: A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

1w agoTrial registeredJul 7, 2026Source filing (opens the source filing in a new tab)

Momentum

77no change

Momentum 77 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Jun 24, 2021

    Crohn Disease, Colitis, Ulcerative · RECRUITING · sponsor: Janssen Scientific Affairs, LLC · A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

    ClinicalTrials.gov · NCT04372108 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Mar 31, 2017

    Suicidality · COMPLETED · sponsor: Janssen Scientific Affairs, LLC · A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment

    ClinicalTrials.gov · NCT03085108 (opens the source filing in a new tab)

  3. Trial

    PHASE4 registered

    Apr 1, 2016

    Inflammatory Bowel Diseases · TERMINATED · sponsor: Janssen Scientific Affairs, LLC · An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease

    ClinicalTrials.gov · NCT02566889 (opens the source filing in a new tab)

  4. Trial

    Study registered

    Dec 1, 2015

    Prostate Cancer · COMPLETED · sponsor: Janssen Scientific Affairs, LLC · Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

    ClinicalTrials.gov · NCT02663193 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources